The Patient Protection and Affordable Care Act and the Health
Care and Education Reconciliation Act will re-shape the business
and delivery of health care for this decade and well beyond. At this
juncture, it is not enough to simply study the detailed provisions
of the Acts. Organizations must carefully consider the
implications and strategic viewpoint for positioning themselves
going forward.
Join two nationally prominent experts:
Paul Keckley, PhD, Executive Director of the Deloitte Center for
Health Solutions, and Doug Hastings, Chair of the Board of
Directors, Epstein Becker & Green, as they guide you through the
strategic perspectives and applicable implications of the Acts, with
particular emphasis on purchasers and providers, and payment and
delivery system reform. |
Paul Keckley, PhD
Executive Director of the Deloitte Center for Health Solutions,
Deloitte LLP
|
|
Paul H. Keckley, Ph.D., is Executive Director for the Deloitte Center for
Health Solutions (“the Center”), the health care research arm of
Deloitte LLP. He brings a distinguished 30 year career in health
services research in the private sector and academic medicine. He is a
health economist and policy expert, and a regular contributor to CNN and
Fox News health reform coverage. The Deloitte Center for Health
Solutions’ studies focus on trends and issues in developed and
developing systems of care around three major themes: reform of health
systems, disruptive innovations that change the structure and
performance of systems, and the role of consumers. Recent topics include
personalized therapeutics, retail medicine, the medical home, medical
tourism, episode-based payments and a survey of 14,000 consumers in
Germany, Canada, U.S., Switzerland, France, and the United Kingdom, to
assess opinions and unmet needs. The Center’s findings are featured
regularly in The Wall Street Journal, The New York Times, Bloomberg, CNN
and Fox News, as well as trade and professional periodicals.
Dr. Keckley is considered one of the country’s leading experts on U.S.
health reform. He has testified before Congress, and recently
facilitated a series of meetings for the White House Office of Health
Reform with AHA, AHIP, PhRMA, AMA, and other trade organizations to
identify mechanisms to reduce costs without compromising quality and
access. Prior to joining Deloitte, Dr. Keckley served in leadership
roles at Vanderbilt Medical Center including international joint
ventures, the Vanderbilt Center for Integrative Health, the health care
MBA program launch, and as Executive Director of the Vanderbilt Center
for Evidence-based Medicine (VCEBM). He has published several articles
in peer reviewed journals and continues to serve in the Vanderbilt
University School of Medicine as a Visiting Professor and the Owen
Graduate School of Business at Vanderbilt as an Adjunct Professor.
Before joining Vanderbilt, Dr. Keckley served as Chairman of the Board
of Interdent, a California dental practice management company; Chief
Executive Officer of EBM Solutions, a joint venture created by
Vanderbilt, Duke, Emory and Washington University-St. Louis; Chief
Executive Officer of Aveta (formerly the IPA Management subsidiary of
PhyCor Inc.), and Principal of The Keckley Group, a strategic planning
consulting practice that served 1,200 U.S. provider organizations and
health plans. Dr. Keckley is a member of the Health Executive Network,
Healthcare Strategy Institute, Healthcare Leadership Council, Owen
Graduate School of Management at Vanderbilt University Advisory Board,
Lipscomb University College of Pharmacy Advisory Board, and the
Personalized Medicine Coalition. He has authored three books and more
than 200 articles, and publishes the Monday Health Reform Memo (www.deloitte.com/centerforhealthsolutions).
He has keynoted national meetings of the American College of Health
Executives, Medical Group Management Association, World Hospital
Association, Medical Travel Association, Convenient Care Association,
American Medical Association House of Delegates, America’s Health
Insurance Plans, the Personalized Medicine Coalition, eHealth
Initiative, American Hospital Association, National Quality Forum and
others. In 2007, he appeared with Michael Moore in a CNN series about
the “facts” in Mr. Moore’s controversial documentary “SiCKO”. Dr.
Keckley enjoys golf and running. He completed his BA at Lipscomb
University, MA and PhD degrees from Ohio State University, and a
fellowship in economic policy at Oxford University.
|
|
|
|
|
|
|
Doug Hastings
Chair of the Board of Directors, Epstein Becker & Green,
P.C. |
|
Douglas A. Hastings currently serves as
Chair of the Board of Directors of Epstein Becker & Green,
P.C. He is a Member of the Firm's Health Care and Life
Sciences Practice in the Washington, DC office. Mr. Hastings
provides a wide range of health care organizations with
strategic and transactional legal guidance in responding to
the legal challenges and opportunities of the rapidly
changing U.S. health care system.
Mr. Hastings serves on the Board on Health Care Services of
the Institute of Medicine and is a member of the Advisory
Board of the BNA's Health Law Reporter. He served on the
Board of Directors of the American Health Lawyers
Association from 1991 to 2003, and was President of that
organization for 2001-2002.
Mr. Hastings' clients include academic medical centers;
hospitals and health systems; faculty practices, medical
groups and other physician organizations; health plans and
other managed care organizations; long-term care facilities;
investment banks and venture funds; and other health
care-related entities. He focuses on representing these
organizations in mergers, acquisitions, joint ventures,
governance issues, complex contractual arrangements and
other affiliations and collaborative efforts. Mr. Hastings
and his colleagues also provide his clients with a full
range of legal advice and services, including: antitrust
law; Medicare reimbursement and other third party payment
issues; Stark, fraud and abuse, and other health care
compliance issues; tax and tax-exempt counseling; privacy
law; bankruptcy and restructuring; real estate and
construction law; labor and employment law; and liability
and litigation matters.
Mr. Hastings has been named by Best Lawyers as the
"Washington, DC Health Care Lawyer of the Year" for 2010. He
is listed in Chambers USA Leading Lawyers for Business, The
Best Lawyers in America, Washington DC Super Lawyers, and
Who's Who in American Law. In 2006, Mr. Hastings was named
one of the DC Area's Top Life Sciences Attorneys by the
Legal Times. In 2004, Nightingale's Healthcare News listed
him as one of the nation's leading healthcare transaction
lawyers. In 1997, the National Law Journal named him as one
of "40 Health Care Lawyers Who Have Made Their Mark." From
1991 through 1999, he served as Program Chair of the Managed
Care Law Institute of the American Health Lawyers
Association. He is a graduate of Duke University and the
University of Virginia Law School.
Mr. Hastings speaks and publishes regularly on topics
related to health care law, complex health care
transactions, corporate governance, collaborative health
care ventures, legal issues related to quality improvement
and the legal trends influencing the U.S. health care
system. |
|
|
|
|
|
|
